Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript

Publishing Fee

 

Overview

The Pharmacophore journal operates under a fully open-access model, ensuring that all published articles are freely and permanently available online immediately upon publication — with no subscription barriers for readers anywhere in the world.

To sustain the editorial and production infrastructure required to maintain this access model, authors are required to pay an Article Processing Charge (APC) upon acceptance of their manuscript. Submission to the journal is free of charge; the APC is invoiced only after a manuscript has successfully completed peer review and been accepted for publication.

 

Standard APC

USD 420

Effective January 1, 2025

Charge covers

  • DOI assignment and registration
  • Galley proof preparation
  • Professional copyediting
  • Permanent open-access hosting

 

Note: The APC applies per accepted manuscript. Submission is free and authors are not charged at the point of submission. The charge is due only upon acceptance.

 

Waiver Program

Fee Waivers for Low- and Middle-Income Countries

To promote equitable global participation in scholarly publishing, the journal provides APC waivers for authors from low- and middle-income countries. Waiver eligibility is determined by the corresponding author's institutional affiliation at the time of submission, in alignment with the Research4Life eligibility framework. Authors must request a waiver during the manuscript submission process.

 

GROUP A — FULL WAIVER

Up to 100%

Authors affiliated with Group A institutions may apply for a full waiver of the standard APC during the submission process.

GROUP B — PARTIAL WAIVER

Up to 50%

Authors affiliated with Group B institutions may apply for a partial waiver of up to 50% of the standard APC during submission.

 

Important: Waiver requests from countries outside of the two tiers described above may not be considered. Eligibility is assessed solely on the basis of the corresponding author's listed affiliation — not the author's nationality or place of residence.

 

Withdrawal Policy

Manuscript Withdrawal Terms

The following terms govern the withdrawal of manuscripts at each stage of the editorial process:

 

Before preliminary review

Withdrawal is permitted without penalty. Prior to editorial screening, participation is entirely voluntary and authors may withdraw their submission at any stage without incurring any charges or sanctions.

 

After preliminary review has commenced

Once a manuscript has entered the peer-review process, withdrawal is no longer permitted without penalty. In recognition of the substantial time and resources invested by editors, peer reviewers, and the publisher, authors who request withdrawal after this stage will be subject to a withdrawal penalty equivalent to the full standard APC (USD 420) per manuscript.

 

Eligible countries

Country Lists

The following countries are eligible for APC waivers under the Research4Life framework. Eligibility is determined by the corresponding author's institutional affiliation.

 

Group A — Full Waiver Eligible (up to 100%)

Afghanistan

Mali

Angola

Marshall Islands

Bangladesh

Mauritania

Belize

Micronesia (Fed. States)

Benin

Mozambique

Bhutan

Myanmar

Burkina Faso

Nauru

Burundi

Nepal

Cabo Verde

Nicaragua

Cambodia

Niger

Cameroon

Niue

Central African Republic

Occupied Palestinian Territory

Chad

Palau

Comoros

Papua New Guinea

Congo

Rwanda

Cook Islands

Saint Helena

Côte d'Ivoire

Saint Lucia

Dem. People's Rep. of Korea

Saint Vincent & the Grenadines

Dem. Republic of the Congo

Samoa

Djibouti

São Tomé and Príncipe

Dominica

Senegal

Equatorial Guinea

Solomon Islands

Eritrea

Somalia

Eswatini

South Sudan

Ethiopia

Sudan

Gambia

Suriname

Ghana

Syrian Arab Republic

Grenada

Tajikistan

Guinea

Timor-Leste

Guinea-Bissau

Togo

Haiti

Tokelau

Kenya

Tonga

Kiribati

Tuvalu

Kyrgyzstan

Uganda

Lao PDR

Ukraine

Lebanon

United Republic of Tanzania

Lesotho

Vanuatu

Liberia

Venezuela (Bolivarian Republic of)

Madagascar

Yemen

Malawi

Zambia

Sierra Leone

Zimbabwe

 

Group B — Partial Waiver Eligible (up to 50%)

Albania

Jordan

Algeria

Kosovo

Antigua and Barbuda

Libya

Armenia

Maldives

Azerbaijan

Mauritius

Bolivia

Mongolia

Bosnia and Herzegovina

Montenegro

Botswana

Morocco

Colombia

Namibia

Cuba

Nigeria

Ecuador

North Macedonia

Egypt

Pakistan

El Salvador

Paraguay

Fiji

Republic of Moldova

Gabon

Saint Kitts and Nevis

Georgia

Seychelles

Guatemala

Sri Lanka

Guyana

Tunisia

Honduras

Uzbekistan

Iraq

Venezuela

Jamaica

Viet Nam

 

Pharmacophore
ISSN: 2229-5402

Copyright © 2026 Pharmacophore. Authors retain copyright of their article if they are accepted for publication.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.